BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hermanson G, Chun S, Felgner J, Tan X, Pablo J, Nakajima-Sasaki R, Molina DM, Felgner PL, Liang X, Davies DH. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs. Vaccine 2012;30:614-25. [PMID: 22100890 DOI: 10.1016/j.vaccine.2011.11.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Tree JA, Flick-Smith H, Elmore MJ, Rowland CA. The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents. J Immunol Res 2014;2014:237043. [PMID: 25333059 DOI: 10.1155/2014/237043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Kumar A, Yogisharadhya R, Venkatesan G, Bhanuprakash V, Shivachandra SB. Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models. Antiviral Research 2016;126:108-16. [DOI: 10.1016/j.antiviral.2015.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bliss CM, Bowyer G, Anagnostou NA, Havelock T, Snudden CM, Davies H, de Cassan SC, Grobbelaar A, Lawrie AM, Venkatraman N, Poulton ID, Roberts R, Mange PB, Choudhary P, Faust SN, Colloca S, Gilbert SC, Nicosia A, Hill AVS, Ewer KJ. Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Sci Rep 2018;8:3390. [PMID: 29467399 DOI: 10.1038/s41598-018-21630-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
4 Fulton KM, Twine SM. Immunoproteomics: Current Technology and Applications. In: Fulton KM, Twine SM, editors. Immunoproteomics. Totowa: Humana Press; 2013. pp. 21-57. [DOI: 10.1007/978-1-62703-589-7_2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
5 Tan X, Chun S, Pablo J, Felgner P, Liang X, Davies DH. Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after. Clin Vaccine Immunol 2012;19:418-28. [PMID: 22258709 DOI: 10.1128/CVI.05521-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Kennedy RB, Ovsyannikova IG, Haralambieva IH, Grill DE, Poland GA. Proteomic assessment of humoral immune responses in smallpox vaccine recipients. Vaccine 2021:S0264-410X(21)01642-X. [PMID: 34952760 DOI: 10.1016/j.vaccine.2021.12.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Haralambieva IH, Simon WL, Kennedy RB, Ovsyannikova IG, Warner ND, Grill DE, Poland GA. Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays. Viruses 2015;7:1113-33. [PMID: 25763865 DOI: 10.3390/v7031113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
8 Manzano-Román R, Dasilva N, Díez P, Díaz-Martín V, Pérez-Sánchez R, Orfao A, Fuentes M. Protein arrays as tool for studies at the host-pathogen interface. J Proteomics 2013;94:387-400. [PMID: 24140974 DOI: 10.1016/j.jprot.2013.10.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
9 Furman D, Davis MM. New approaches to understanding the immune response to vaccination and infection. Vaccine 2015;33:5271-81. [PMID: 26232539 DOI: 10.1016/j.vaccine.2015.06.117] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 10.4] [Reference Citation Analysis]
10 Altenburg AF, van Trierum SE, de Bruin E, de Meulder D, van de Sandt CE, van der Klis FRM, Fouchier RAM, Koopmans MPG, Rimmelzwaan GF, de Vries RD. Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines. Sci Rep 2018;8:6474. [PMID: 29692427 DOI: 10.1038/s41598-018-24820-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Felgner J, Juarez S, Hung C, Liang LI, Jain A, Döşkaya M, Felgner PL, Caner A, Gürüz Y, Davies DH. Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling. Parasitology 2015;142:827-38. [PMID: 25586591 DOI: 10.1017/S0031182014001978] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kalantari-Dehaghi M, Chun S, Chentoufi AA, Pablo J, Liang L, Dasgupta G, Molina DM, Jasinskas A, Nakajima-Sasaki R, Felgner J, Hermanson G, BenMohamed L, Felgner PL, Davies DH. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J Virol 2012;86:4328-39. [PMID: 22318154 DOI: 10.1128/JVI.05194-11] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
13 Keckler MS, Reynolds MG, Damon IK, Karem KL. The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data. Vaccine 2013;31:5192-201. [PMID: 23994378 DOI: 10.1016/j.vaccine.2013.08.039] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rampling T, Ewer KJ, Bowyer G, Edwards NJ, Wright D, Sridhar S, Payne R, Powlson J, Bliss C, Venkatraman N, Poulton ID, de Graaf H, Gbesemete D, Grobbelaar A, Davies H, Roberts R, Angus B, Ivinson K, Weltzin R, Rajkumar BY, Wille-Reece U, Lee C, Ockenhouse C, Sinden RE, Gerry SC, Lawrie AM, Vekemans J, Morelle D, Lievens M, Ballou RW, Lewis DJM, Cooke GS, Faust SN, Gilbert S, Hill AVS. Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP. NPJ Vaccines 2018;3:49. [PMID: 30323956 DOI: 10.1038/s41541-018-0084-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
15 Frey SE, Stapleton JT, Ballas ZK, Rasmussen WL, Kaufman TM, Blevins TP, Jensen TL, Davies DH, Tary-Lehmann M, Chaplin P, Hill H, Goll JB; DMID 09-0002 MVA Vaccine Study Group . Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses. J Infect Dis 2021;224:1372-82. [PMID: 33675226 DOI: 10.1093/infdis/jiab111] [Reference Citation Analysis]
16 Davies DH, Chun S, Hermanson G, Tucker JA, Jain A, Nakajima R, Pablo J, Felgner PL, Liang X. T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association. J Immunol 2014;193:1812-27. [PMID: 25024392 DOI: 10.4049/jimmunol.1400663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Nayak K, Jing L, Russell RM, Davies DH, Hermanson G, Molina DM, Liang X, Sherman DR, Kwok WW, Yang J, Kenneth J, Ahamed SF, Chandele A, Murali-Krishna K, Koelle DM. Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening. Tuberculosis (Edinb) 2015;95:275-87. [PMID: 25857935 DOI: 10.1016/j.tube.2015.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
18 Eto A, Yamamoto N, Kanatani Y. Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain. Biology (Basel) 2021;10:1158. [PMID: 34827150 DOI: 10.3390/biology10111158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Keckler MS, Salzer JS, Patel N, Townsend MB, Nakazawa YJ, Doty JB, Gallardo-Romero NF, Satheshkumar PS, Carroll DS, Karem KL, Damon IK. IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model. Vaccines (Basel) 2020;8:E396. [PMID: 32698399 DOI: 10.3390/vaccines8030396] [Reference Citation Analysis]
20 Pezeshki A, Ovsyannikova IG, McKinney BA, Poland GA, Kennedy RB. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines. Expert Rev Vaccines 2019;18:253-67. [PMID: 30700167 DOI: 10.1080/14760584.2019.1575208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
21 Pinne M, Matsunaga J, Haake DA. Leptospiral outer membrane protein microarray, a novel approach to identification of host ligand-binding proteins. J Bacteriol 2012;194:6074-87. [PMID: 22961849 DOI: 10.1128/JB.01119-12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
22 Townsend MB, Keckler MS, Patel N, Davies DH, Felgner P, Damon IK, Karem KL. Humoral Immunity to Smallpox Vaccines and Monkeypox Virus Challenge: Proteomic Assessment and Clinical Correlations. J Virol 2013;87:900-11. [DOI: 10.1128/jvi.02089-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]